Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Savills CEO to stand down at end of 2025

(Sharecast News) - Real estate services firm Savills announced on Tuesday that chief executive Mark Ridley will retire at the end of 2025 after a 29-year career with the group. Ridley will be succeeded by chief financial officer Simon Shaw, who joined Savills in 2009, on 1 January 2026.

The FTSE 250-listed firm stated that the search for a new group chief financial officer had now commenced.

Chair Stacey Cartwright said: "Under Mark's leadership, Savills has achieved significant growth and stronger balance, both geographically and by service line. He has successfully steered the business through Brexit and its aftermath and the pandemic years, and more recently, global macroeconomic and geopolitical headwinds, navigating these very significant challenges whilst growing the business at the same time."

Cartwright also noted that following Ridley's retirement, he will remain available in a senior advisory role supporting the business.

As of 0840 BST, Savills shares were down 0.63% at 939.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.